Product Details
| Product Name:
GW-406381 |
CAS No.:
221148-46-5 |
| Supply Ability:
10g |
Release date:
2025/10/31 |
Product Introduction
Bioactivity
| Name | GW-406381 |
| Description | GW406381 is a highly selective inhibitor of cyclooxygenase-2 (COX-2). GW406381 also attenuates spontaneous ectopic discharge in the sural nerves of rats following chronic constriction injury. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Keywords | GW-406381 | GW406381 | GW 406381 | COX-2 |
| Inhibitors Related | Bismuth Subsalicylate | Ibuprofen | Acetaminophen | Salicylamide | Diclofenac sodium | Diclofenac Potassium | trans-Cinnamaldehyde | Paradol | Indomethacin sodium hydrate | Salicylic acid | Glafenine | Revaprazan hydrochloride |
Company Profile Introduction
TargetMol Chemicals Inc. is headquartered in Boston, MA, and specializes in products and services that serve the research needs of chemical and biological scientists worldwide. With a client base in 40+ countries, TargetMol has evolved into one of the biggest global research suppliers for compound libraries and small molecule compounds.
170+ Compound Libraries， 10000+ Noval Small Molecucles，16000+ Nature Compounds
TargetMol diligently updates and offers over 170 types of compound libraries and a wide range of high-quality research chemicals, including inhibitors, activators, natural products, peptides, antibodies , and novel life-science kits for laboratory and scientific use. In addition, our lab allows us to conduct CADD (computer-aided drug design) and chemical synthesis to meet the customization needs of our clients.
You may like
-
CAS:537697-89-5
$2180.00 / 50mg
-
CAS:210237-78-8
$2580.00 / 50mg
-
CAS:329936-49-4
$1820.00 / 25mg
Recommended supplier
| Product name |
Price |
|
Suppliers |
Update time |
|
|
$10.00/1ASSAYS |
VIP5Y
|
RongNa Biotechnology Co.,Ltd
|
2025-05-16 |
|
|
$5.00/1Box |
VIP1Y
|
Hebei Jiafan Trading Company Limited
|
2025-03-07 |
|
|
$0.00/1kg |
VIP2Y
|
Shaanxi Xianhe Biotech Co., Ltd
|
2025-04-14 |
United States